Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 18
1979 34
1980 29
1981 25
1982 22
1983 32
1984 27
1985 31
1986 47
1987 39
1988 36
1989 37
1990 51
1991 39
1992 57
1993 64
1994 81
1995 61
1996 76
1997 71
1998 73
1999 58
2000 55
2001 43
2002 37
2003 49
2004 39
2005 38
2006 49
2007 48
2008 24
2009 31
2010 22
2011 23
2012 23
2013 14
2014 14
2015 16
2016 20
2017 20
2018 18
2019 15
2020 11
2021 4
2022 13
2023 15
2024 10
2025 8
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,605 results

Results by year

Filters applied: . Clear all
Page 1
The pharmacology of selegiline.
Magyar K. Magyar K. Int Rev Neurobiol. 2011;100:65-84. doi: 10.1016/B978-0-12-386467-3.00004-2. Int Rev Neurobiol. 2011. PMID: 21971003 Review.
Selegiline-transdermal--Somerset: Emsam.
[No authors listed] [No authors listed] Drugs R D. 2003;4(1):59-60. doi: 10.2165/00126839-200304010-00012. Drugs R D. 2003. PMID: 12568641 Review. No abstract available.
Transdermal selegiline.
Patkar AA, Pae CU, Zarzar M. Patkar AA, et al. Drugs Today (Barc). 2007 Jun;43(6):361-77. doi: 10.1358/dot.2006.43.6.1050794. Drugs Today (Barc). 2007. PMID: 17612708 Review.
Neuroprotective actions of selegiline.
Ebadi M, Sharma S, Shavali S, El Refaey H. Ebadi M, et al. J Neurosci Res. 2002 Feb 1;67(3):285-9. doi: 10.1002/jnr.10148. J Neurosci Res. 2002. PMID: 11813232 Review.
Selegiline: a molecule with innovative potential.
Tábi T, Vécsei L, Youdim MB, Riederer P, Szökő É. Tábi T, et al. J Neural Transm (Vienna). 2020 May;127(5):831-842. doi: 10.1007/s00702-019-02082-0. Epub 2019 Sep 27. J Neural Transm (Vienna). 2020. PMID: 31562557 Free PMC article. Review.
Metabolism of selegiline [(-)-deprenyl)].
Kalász H, Magyar K, Szőke É, Adeghate E, Adem A, Hasan MY, Nurulain SM, Tekes K. Kalász H, et al. Curr Med Chem. 2014;21(13):1522-30. doi: 10.2174/0929867321666131218094352. Curr Med Chem. 2014. PMID: 24350849 Review.
Rasagiline.
Schapira A, Bate G, Kirkpatrick P. Schapira A, et al. Nat Rev Drug Discov. 2005 Aug;4(8):625-6. doi: 10.1038/nrd1803. Nat Rev Drug Discov. 2005. PMID: 16106586 No abstract available.
Safety of selegiline with cold medications.
Jacob JE, Wagner ML, Sage JI. Jacob JE, et al. Ann Pharmacother. 2003 Mar;37(3):438-41. doi: 10.1345/aph.1C175. Ann Pharmacother. 2003. PMID: 12639177 Review.
1,605 results